Hepion Pharmaceuticals, Inc. also files under HEPA; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | LoPriore Chase | VP, Corp. Dev., Director | Grant(A) | 1.3M | — | $0 |
| Aug 19, 2026 | LoPriore Vincent S | Executive Chairman, Director | Grant(A) | 1.3M | — | $0 |
| Aug 19, 2026 | Fisher Danina | Director | Grant(A) | 299K | — | $0 |
| Aug 19, 2026 | Stetz Gary S. | Interim CEO, Director | Grant(A) | 1.3M | — | $0 |
| Aug 19, 2026 | Stetz Gary S. II | Director | Grant(A) | 299K | — | $0 |
| Aug 19, 2026 | Liddy James Gordon | Director | Grant(A) | 299K | — | $0 |
| Aug 19, 2026 | Appajosyula Sireesh | Chief Operating Officer, Director | Grant(A) | 1.3M | — | $0 |
| Aug 3, 2026 | LoPriore Vincent S | Executive Chairman, Director | Buy(P) | 8.0M | $0.05 | $400K |
| Aug 3, 2026 | Appajosyula Sireesh | Chief Operating Officer, Director | Buy(P) | 2.0M | $0.05 | $100K |
| Aug 3, 2026 | Purcell Michael J. | Director | Buy(P) | 2.0M | — | $0 |
| Aug 3, 2026 | Purcell Michael J. | Director | Buy(P) | 2.0M | $0.05 | $100K |
| Aug 3, 2026 | Stetz Gary S. II | Director | Buy(P) | 500K | — | $0 |
| Aug 3, 2026 | Stetz Gary S. II | Director | Buy(P) | 500K | $0.05 | $25K |
| Aug 3, 2026 | LoPriore Vincent S | Executive Chairman, Director | Buy(P) | 2.0M | — | $0 |
| Aug 3, 2026 | LoPriore Vincent S | Executive Chairman, Director | Buy(P) | 8.0M | — | $0 |
| Aug 3, 2026 | LoPriore Vincent S | Executive Chairman, Director | Buy(P) | 2.0M | $0.05 | $100K |
| Aug 3, 2026 | Appajosyula Sireesh | Chief Operating Officer, Director | Buy(P) | 2.0M | — | $0 |
| Aug 3, 2026 | Stetz Gary S. | Interim CEO, Director | Buy(P) | 2.0M | — | $0 |
| Aug 3, 2026 | Stetz Gary S. | Interim CEO, Director | Buy(P) | 2.0M | $0.05 | $100K |
| Apr 21, 2026 | Stetz Gary S. | Interim CEO, Director | Buy(P) | 1.3M | $0.04 | $50K |
| Apr 21, 2026 | Appajosyula Sireesh | Director | Buy(P) | 1.3M | $0.04 | $50K |
| Apr 21, 2026 | LoPriore Vincent S | Executive Chairman, Director, 10% Owner | Buy(P) | 5.0M | $0.04 | $200K |
| Apr 21, 2026 | LoPriore Vincent S | Executive Chairman, Director, 10% Owner | Buy(P) | 1.3M | $0.04 | $50K |
| Apr 21, 2026 | Purcell Michael J. | Director | Buy(P) | 1.3M | $0.04 | $50K |
| Mar 6, 2024 | Purcell Michael J. | Director | Grant(A) | 50K | — | $0 |
| Feb 19, 2024 | Jacob Gary S | Director | Grant(A) | 85K | — | $0 |
| Feb 19, 2024 | Brancaccio John P | Chairman, Director | Grant(A) | 85K | — | $0 |
| Feb 19, 2024 | Lbiati Kaouthar | Director | Grant(A) | 85K | — | $0 |
| Feb 19, 2024 | Block Timothy M. | Director | Grant(A) | 85K | — | $0 |
| Nov 27, 2023 | Wijngaard Peter | Director | Buy(P) | 3K | $3.05 | $8K |
| Nov 24, 2023 | Wijngaard Peter | Director | Buy(P) | 3K | $3.09 | $8K |
| Sep 19, 2023 | Wijngaard Peter | Director | Buy(P) | 1K | $5.64 | $6K |
| Sep 18, 2023 | Foster Robert T | CEO and Director, Director | Buy(P) | 2K | $5.60 | $9K |
| Sep 15, 2023 | Foster Robert T | CEO,CSO and Director, Director | Buy(P) | 2K | $5.40 | $9K |
| Sep 15, 2023 | Wijngaard Peter | Director | Buy(P) | 1K | $5.82 | $6K |
| Sep 15, 2023 | Wijngaard Peter | Director | Buy(P) | 139 | $5.45 | $758 |
| Sep 15, 2023 | Wijngaard Peter | Director | Buy(P) | 861 | $5.37 | $5K |
| May 18, 2021 | Cavan John T | Chief Financial Officer | Grant(A) | 1.2M | — | $0 |
| May 18, 2021 | Foster Robert T | CEO, CSO and Director, Director | Grant(A) | 1.9M | — | $0 |
| May 18, 2021 | Jacob Gary S | Director | Grant(A) | 250K | — | $0 |
| May 18, 2021 | Wijngaard Peter | Director | Grant(A) | 200K | — | $0 |
| May 18, 2021 | Lippa Arnold | Director | Grant(A) | 200K | — | $0 |
| May 18, 2021 | Adams Thomas PHD | Director | Grant(A) | 200K | — | $0 |
| May 18, 2021 | Block Timothy M. | Director | Grant(A) | 200K | — | $0 |
| May 18, 2021 | Brancaccio John P | Director | Grant(A) | 200K | — | $0 |
| Feb 18, 2021 | Foster Robert T | CEO and Director, Director | Buy(P) | 20K | $2.00 | $40K |
| Feb 18, 2021 | Cavan John T | Chief Financial Officer | Buy(P) | 10K | $2.00 | $20K |
| Feb 16, 2021 | Wijngaard Peter | Director | Buy(P) | 10K | $2.20 | $22K |
| Dec 18, 2020 | Wijngaard Peter | Director | Buy(P) | 20K | $1.91 | $38K |
| Dec 8, 2020 | Foster Robert T | CEO and Director, Director | Buy(P) | 25K | $1.58 | $40K |
| Dec 2, 2020 | Brancaccio John P | Director | Buy(P) | 7K | $1.53 | $11K |
| Dec 1, 2020 | Jacob Gary S | Director | Buy(P) | 12K | $1.66 | $20K |
| Nov 25, 2020 | Cavan John T | Chief Financial Officer | Buy(P) | 5K | $1.62 | $7K |
| Aug 19, 2020 | Foster Robert T | CEO,CSO and Director, Director | Grant(A) | 212K | — | $0 |
| Aug 19, 2020 | Cavan John T | Chief Financial Officer | Grant(A) | 160K | — | $0 |
| Aug 19, 2020 | Wijngaard Peter | Director | Grant(A) | 30K | — | $0 |
| Aug 19, 2020 | Jacob Gary S | Director | Grant(A) | 30K | — | $0 |
| Aug 19, 2020 | Brancaccio John P | Director | Grant(A) | 30K | — | $0 |
| Aug 19, 2020 | Adams Thomas PHD | Director | Grant(A) | 30K | — | $0 |
| Aug 19, 2020 | Block Timothy M. | Director | Grant(A) | 30K | — | $0 |
| Aug 19, 2020 | Lippa Arnold | Director | Grant(A) | 30K | — | $0 |
| Jun 25, 2020 | Wijngaard Peter | Director | Grant(A) | 30K | — | $0 |
| Apr 3, 2020 | Adams Thomas PHD | Director | Grant(A) | 60K | — | $0 |
| Apr 3, 2020 | Block Timothy M. | Director | Grant(A) | 60K | — | $0 |
| Apr 3, 2020 | Lippa Arnold | Director | Grant(A) | 60K | — | $0 |
| Apr 3, 2020 | Brancaccio John P | Director | Grant(A) | 60K | — | $0 |
| Apr 3, 2020 | Foster Robert T | CEO and CSO, Director | Grant(A) | 380K | — | $0 |
| Apr 3, 2020 | Cavan John T | Chief Financial Officer | Grant(A) | 215K | — | $0 |
| Apr 3, 2020 | Jacob Gary S | Director | Grant(A) | 60K | — | $0 |
| Jul 24, 2019 | Cavan John T | Chief Financial Officer | Grant(A) | 6K | — | $0 |
| Jul 24, 2019 | Lippa Arnold | Director | Grant(A) | 970 | — | $0 |
| Jul 24, 2019 | Foster Robert T | CEO and CSO, Director | Grant(A) | 10K | — | $0 |
| Jul 24, 2019 | Adams Thomas PHD | Director | Grant(A) | 970 | — | $0 |
| Jul 24, 2019 | Block Timothy M. | Director | Grant(A) | 970 | — | $0 |
| Jul 24, 2019 | Brancaccio John P | Director | Grant(A) | 970 | — | $0 |
| Jul 24, 2019 | Jacob Gary S | Director | Grant(A) | 970 | — | $0 |
| Jul 3, 2018 | Cavan John T | CFO | Buy(P) | 15 | $1,000.00 | $15K |
| Jul 3, 2018 | Cavan John T | CFO | Buy(P) | 9K | $1,000.00 | $8.6M |
| Jul 3, 2018 | Lippa Arnold | Director | Buy(P) | 9K | $1,000.00 | $8.6M |
| Jul 3, 2018 | Lippa Arnold | Director | Buy(P) | 15 | $1,000.00 | $15K |
| Jul 3, 2018 | Brancaccio John P | Director | Buy(P) | 3 | $1,000.00 | $3K |
| Jul 3, 2018 | Brancaccio John P | Director | Buy(P) | 2K | $1,000.00 | $1.7M |
| Jul 3, 2018 | Jacob Gary S | Director | Buy(P) | 9K | $1,000.00 | $8.6M |
| Jul 3, 2018 | Jacob Gary S | Director | Buy(P) | 15 | $1,000.00 | $15K |
| Jan 3, 2018 | Cavan John T | CFO | Grant(A) | 101K | — | $0 |
| Jan 3, 2018 | Foster Robert T | Chief Scientific Officer | Grant(A) | 101K | — | $0 |
| Jan 3, 2018 | Sapirstein James | Chief Executive Officer, Director | Grant(A) | 322K | — | $0 |
| Jul 20, 2017 | Cavan John T | Chief Financial Officer | Grant(A) | 15K | — | $0 |
| Jul 6, 2017 | Sullivan-Bolyai John Z | Chief Medical Officer | Grant(A) | 59K | — | $0 |
| Jul 6, 2017 | Foster Robert T | Chief Scientific Officer | Grant(A) | 44K | — | $0 |
| Jul 6, 2017 | Sapirstein James | Chief Executive Officer, Director | Grant(A) | 141K | — | $0 |
| Jul 6, 2017 | Cavan John T | CFO | Grant(A) | 47K | — | $0 |
| Jun 20, 2017 | Cavan John T | CFO | Buy(P) | 20K | $0.65 | $13K |
| Apr 10, 2017 | Howson Tamar D | Director | Grant(A) | 35K | — | $0 |
| Mar 6, 2017 | Sapirstein James | Chief Executive Officer, Director | Grant(A) | 314K | — | $0 |
| Mar 3, 2017 | Sapirstein James | Chief Executive Officer, Director | Grant(A) | 314K | — | $0 |
| Oct 27, 2016 | Sapirstein James | Chief Executive Officer, Director | Option exercise(M) | 17K | — | $0 |
| Oct 27, 2016 | Sapirstein James | Chief Executive Officer, Director | Option exercise(M) | 17K | $1.50 | $25K |
| Aug 26, 2016 | Cavan John T | Chief Financial Officer | Grant(A) | 19K | — | $0 |
| Aug 26, 2016 | Sullivan-Bolyai John Z | Chief Medical Officer | Grant(A) | 136K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Hepion Pharmaceuticals, Inc., SEC CIK 0001583771. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under CTRV and shows every filing by that issuer (also filed as HEPA).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-09. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for CTRV